Efficacy and safety of non‐ergot dopamine‐receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta‐analysis

BACKGROUND AND PURPOSE: Non‐ergot dopamine agonists (NEDAs) have been used as an adjunct therapy to levodopa in advanced Parkinson's disease (PD) for many years. However, there is no strong evidence that a given NEDA is more potent than another. To compare and rank the efficacy, tolerability, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiang‐Ting, Zhang, Qian, Wen, Si‐Yuan, Chen, Fei‐Fei, Zhou, Chang‐Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Movement Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099912/
https://www.ncbi.nlm.nih.gov/pubmed/36380711
http://dx.doi.org/10.1111/ene.15635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099912/
https://www.ncbi.nlm.nih.gov/pubmed/36380711
http://dx.doi.org/10.1111/ene.15635

Ejemplares similares